{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:47:08Z","timestamp":1770454028036,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jneuroim.2018.09.010","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T12:13:17Z","timestamp":1537618397000},"page":"115-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Recurrent optic neuritis \u2013 Different patterns in multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody disease"],"prefix":"10.1016","volume":"324","author":[{"given":"Itay","family":"Lotan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Hellmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3097-4693","authenticated-orcid":false,"given":"Felix","family":"Benninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7715-6706","authenticated-orcid":false,"given":"Hadas","family":"Stiebel-Kalish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2018.09.010_bb0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0404.2010.01388.x","article-title":"Bilateral and recurrent optic neuritis in multiple sclerosis","volume":"123","author":"Burman","year":"2011","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0010","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000131","article-title":"Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis","volume":"2","author":"Chalmoukou","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0015","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archneur.58.5.797","article-title":"Recurrence of acute disseminated encephalomyelitis at the previously affected brain site","volume":"58","author":"Cohen","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0020","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","article-title":"Multiple sclerosis--the plaque and its pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0025","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000135","article-title":"Acute optic neuritis: unmet clinical needs and model for new therapies","volume":"2","author":"Galetta","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archneur.1992.00530270075021","article-title":"Magnetic resonance imaging lesion enlargement in multiple sclerosis. Disease-related activity, chance occurrence, or measurement artifact?","volume":"49","author":"Goodkin","year":"1992","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-2094-5-22","article-title":"Neuromyelitis optica pathogenesis and aquaporin 4","volume":"5","author":"Graber","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079083","article-title":"An optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assays","volume":"8","author":"Hoftberger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0045","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/1352458514555785","article-title":"Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease","volume":"21","author":"Hoftberger","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0050","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype","volume":"79","author":"Kitley","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0055","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1212\/WNL.39.7.959","article-title":"The lesion of multiple sclerosis: imaging of acute and chronic stages","volume":"39","author":"Koopmans","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ncl.2017.08.002","article-title":"Multiple sclerosis: mechanisms of disease and strategies for myelin and axonal repair","volume":"36","author":"Lemus","year":"2018","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0065","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0070","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/archneurol.2011.1974","article-title":"Low serum vitamin D levels and recurrent inflammatory spinal cord disease","volume":"69","author":"Mealy","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0075","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0080","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12974-016-0720-6","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients","volume":"13","author":"Pache","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0085","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrneurol.2014.108","article-title":"The investigation of acute optic neuritis: a review and proposed protocol","volume":"10","author":"Petzold","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0090","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0095","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/brain\/116.3.681","article-title":"Multiple sclerosis. Pathology of recurrent lesions","volume":"116","author":"Prineas","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0100","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1172\/JCI3568","article-title":"Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis","volume":"102","author":"Qin","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0105","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1212\/WNL.0000000000001066","article-title":"Epitope spreading as an early pathogenic event in pediatric multiple sclerosis","volume":"83","author":"Quintana","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0110","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000060","article-title":"MOG antibody-associated diseases","volume":"2","author":"Reindl","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","article-title":"The spectrum of MOG autoantibody-associated demyelinating diseases","volume":"9","author":"Reindl","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0120","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/archneurol.2011.2956","article-title":"Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis","volume":"69","author":"Rostasy","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0125","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000257","article-title":"Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis","volume":"3","author":"Spadaro","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0130","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/ana.20743","article-title":"Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis","volume":"58","author":"Sriram","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0135","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.22552","article-title":"On human disease and animal models","volume":"70","author":"Steiner","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"Toosy","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0150","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000062","article-title":"Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?","volume":"2","author":"Zamvil","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2018.09.010_bb0155","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000110","article-title":"Aquaporin-4 autoimmunity","volume":"2","author":"Zekeridou","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818303795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818303795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:33:42Z","timestamp":1759048422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572818303795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":31,"alternative-id":["S0165572818303795"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.09.010","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent optic neuritis \u2013 Different patterns in multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}